ALBANY MOLECULAR RESH INC's ticker is AMRI and the CUSIP is 012423109. A total of 135 filers reported holding ALBANY MOLECULAR RESH INC in Q4 2016. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,587,000 | +35.0% | 137,904 | +18.8% | 0.00% | +50.0% |
| Q3 2016 | $1,917,000 | +20.6% | 116,110 | -1.9% | 0.00% | 0.0% |
| Q2 2016 | $1,590,000 | +3.9% | 118,338 | +18.2% | 0.00% | 0.0% |
| Q1 2016 | $1,531,000 | -23.1% | 100,148 | -0.2% | 0.00% | -33.3% |
| Q4 2015 | $1,992,000 | +15.0% | 100,357 | +0.9% | 0.00% | +50.0% |
| Q3 2015 | $1,732,000 | -13.6% | 99,429 | +0.3% | 0.00% | 0.0% |
| Q2 2015 | $2,004,000 | +24.8% | 99,100 | +8.6% | 0.00% | 0.0% |
| Q1 2015 | $1,606,000 | +9.0% | 91,245 | +0.8% | 0.00% | 0.0% |
| Q4 2014 | $1,474,000 | -27.0% | 90,545 | -1.0% | 0.00% | -33.3% |
| Q3 2014 | $2,019,000 | +13.6% | 91,461 | +3.5% | 0.00% | +50.0% |
| Q2 2014 | $1,778,000 | +19.7% | 88,356 | +10.6% | 0.00% | 0.0% |
| Q1 2014 | $1,486,000 | +86.2% | 79,915 | +0.9% | 0.00% | +100.0% |
| Q4 2013 | $798,000 | -23.9% | 79,189 | -2.6% | 0.00% | -50.0% |
| Q3 2013 | $1,048,000 | +12.2% | 81,312 | +3.3% | 0.00% | 0.0% |
| Q2 2013 | $934,000 | – | 78,721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 302,400 | $4,243,000 | 7.26% |
| Permian Investment Partners, LP | 3,181,577 | $44,638,000 | 6.90% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 1,738,764 | $24,395,000 | 2.25% |
| AMERICAN CAPITAL MANAGEMENT INC | 2,157,370 | $30,268,000 | 2.14% |
| Walthausen & Co., LLC | 831,285 | $11,663,000 | 1.20% |
| Netols Asset Management, Inc. | 371,226 | $5,208,000 | 1.17% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,234,440 | $17,319,000 | 0.84% |
| AMI ASSET MANAGEMENT CORP | 705,493 | $9,898,000 | 0.74% |
| Evercore Wealth Management, LLC | 1,040,211 | $14,594,000 | 0.57% |
| Lombard Odier Asset Management (USA) Corp | 421,100 | $5,908,000 | 0.56% |